Searched for
DAINIPPON SUMITOMO PHARMA CO. LTD
Oil slide deepens as Saudi exports reach 90% of pre-war levelBrent futures slipped to near $70 a barrel in London, hitting their lowest since the week before the Iran war began on Feb 28. Saudi Arabia...- I would never have been CEO in any other country, including India: Indra NooyiFormer PepsiCo chief Indra Nooyi credits the US' "meritocratic" system for her success, stating she couldn't have reached CEO status in any...
- Nifty eyes 25,000 as July rally builds; banking, realty and auto lead the charge: Rohit SrivastavaMarket strategist Rohit Srivastava anticipates a strong summer for Indian equities, with the Nifty poised for gains. He highlights banking,...
- Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
- SoftBank completes second $10 billion tranche of its $30 billion OpenAI investmentSoftBank has injected another $10 billion into OpenAI, part of a larger $30 billion commitment. This significant investment, funded by a br...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- PepsiCo commissions second India flavour plant in Ujjain with Rs 1,266-crore investmentPepsiCo India has launched a massive Rs 1,266-crore flavour manufacturing plant in Ujjain, Madhya Pradesh. This significant investment, par...
- SMBC Asia Rising Fund makes follow-on investments worth $12-15 million in three fintech startupsSMBC Asia Rising Fund (ARF) has injected $12-15 million in follow-on investments into Easy Home Finance, Vayana, and DPDzero. These strateg...
- India-Japan Summit: Deepening economic ties and strategic investment opportunities for next decadePrime Minister Takaichi's visit to India highlights a robust economic partnership, with Japan a key player in India's infrastructure and au...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Japan's Nikkei ends 4% lower as SoftBank tanks on OpenAI IPO delay reportJapan's Nikkei index experienced a significant drop of 4% on Friday, largely due to a sharp decline in tech investor SoftBank Group, which ...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Japan's super-long bonds briefly change course to fall after weak auctionJapan's long-dated bond market saw a dip Friday after a 20-year bond auction attracted weak investor interest. Concerns over increased gove...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
Load More
